Recurrent Ovarian Transitional Cell Carcinoma

specific

The reemergence of ovarian transitional cell carcinoma after a period of remission.

40

Centers

43

Active Trials

Cancer Funding

Top Centers for Recurrent Ovarian Transitional Cell Carcinoma(40)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.1
2
NCI Comprehensive
High-Volume Research Center
72.1
3
NCI Comprehensive
High-Volume Research Center
72.1
4
NCI Comprehensive
Active Research Program
49.6
5
NCI Comprehensive
Active Research Program
49.6
6
NCI Comprehensive
Active Research Program
49.6
7
NCI Comprehensive
Active Research Program
49.6
8
NCI Comprehensive
Active Research Program
49.6
9
NCI Comprehensive
Active Research Program
49.6
10
NCI Comprehensive
Active Research Program
49.6
11
NCI Comprehensive
Active Research Program
49.6
12
NCI Comprehensive
Active Research Program
49.6
13
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
49.6
14
NCI Comprehensive
Active Research Program
49.6
15
NCI Comprehensive
Active Research Program
49.6
16
NCI Comprehensive
Active Research Program
49.6
17
NCI Comprehensive
Active Research Program
49.6
18
NCI Comprehensive
Active Research Program
49.6
19
NCI Comprehensive
Active Research Program
49.6
20
NCI Clinical
Active Research Program
49.6
21
NCI Comprehensive
Active Research Program
49.6
22
Active Research Program
49.6
23
Active Research Program
49.6
24
NCI Comprehensive
Active Research Program
49.6
25
NCI Clinical
Active Research Program
49.6
26
NCI Comprehensive
Active Research Program
49.6
27
Active Research Program
49.6
28
NCI Clinical
Active Research Program
49.6
29
NCI Comprehensive
Active Research Program
49.6
30
Active Research Program
49.6
31
Active Research Program
49.6
3249.6
33
Active Research Program
49.6
34
Active Research Program
49.6
35
Active Research Program
49.6
36
Active Research Program
49.6
3749.6
38
Active Research Program
49.6
39
Active Research Program
49.6
40
Active Research Program
49.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →